Mesna Hudklinikk AS
Score · fiscal year 2024
41of 100
How to read this: the company is ahead of 26 % of companies in the Morning class Small in the same sector in 2024. What does this mean?
Rank in the Morning class Small: 251 of 340 · What are Morning company classes?
Place in the whole sector: 1,379 of 1,996 · Helse og omsorg
Profile
Cheetah · Sprinter
High profitability, lower solidity
Position against comparable companies in 2024, not a verdict on the company. Based on profitability 98 and solidity 4 out of 100 among companies in the Morning class Small in the same sector in 2024. Methodology
Against the sector
Mesna Hudklinikk AS is 10 points below the median for companies in the Morning class Small in the same sector in 2024.
Median score 51 among 340 companies.
Against companies in the Morning class Small in the same sector in 2024: operating margin 59.9% (median 5.9%) and equity ratio 0.7% (median 42.8%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 11 MNOK | 21 MNOK |
| Operating margin | 59.9% | 5.9% |
| Profit margin | 59.8% | 5.7% |
| Return on assets | 81.8% | 10.8% |
| Equity ratio | 0.7% | 42.8% |
| Debt-to-equity | 138.41 | 1.23 |
| Current ratio | 0.94 | 1.44 |
| Revenue growth | −0.5% | 7.3% |
| Revenue per employee | 1.40 MNOK | 0.94 MNOK |
The median and “ahead of” refer to companies in the Morning class Small in the same sector in 2024. The bar shows the share of companies the figure is ahead of.
With an index of 41, Mesna Hudklinikk AS does better than 26% of companies in the Morning class Small in the same sector (340 companies) in 2024.
Score 2023–2025
- Mesna Hudklinikk AS
- Median: companies in the Morning class Small in the same sector
What the numbers say
Mesna Hudklinikk AS had an operating margin of 59.9% and an equity ratio of 0.7% in 2024, and ranks 1,379 of 1,996 in Helse og omsorg.
From 2023 to 2024: the operating margin rose from 50.1% to 59.9% and the equity ratio fell from 12.9% to 0.7%.
This text is generated automatically from the 2024 accounts.
Three simple methods
The methods give between 0 MNOK and 59 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 52 MNOK |
| EV/EBIT | 8.0 | 59 MNOK |
| P/B | 1.0 | 0 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- watch
The equity ratio is very low. Could the company absorb a bad year, and does it need more equity?
Based on: Equity ratio 0.7% (median 42.8%).
- watch
Consider strengthening liquidity: current liabilities are 1.1 times current assets.
Based on: Current ratio 0.94 (median 1.44).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 0.1% of the debt in 2024. The policy rate averaged 4.50 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2026, the sector's weakest year, for this company.
The sector's weakest year was 2026, with a median operating margin of −10.4%. Based on the 6 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 98 | weight 30% |
|---|---|---|
| Solidity | 4 | weight 25% |
| Liquidity | 22 | weight 15% |
| Growth | 16 | weight 15% |
| Consistency | 32 | weight 15% |
Durability: 45 (average over 2 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is Mesna Hudklinikk AS?
The operating margin was 59.9% in 2024, against a median of 5.9% among companies in the Morning class Small in the same sector. Return on assets was 81.8%.
How solid is Mesna Hudklinikk AS?
The equity ratio was 0.7% in 2024 (median 42.8%). Debt-to-equity was 138.41 (median 1.23).
What is the liquidity of Mesna Hudklinikk AS like?
The current ratio was 0.94 in 2024 (median 1.44). Current assets did not cover current liabilities.
How does Mesna Hudklinikk AS compare in Helse og omsorg?
Mesna Hudklinikk AS ranks 1,379 of 1,996 in Helse og omsorg for 2024. Among companies in the Morning class Small it is number 251 of 340. Revenue changed by −0.5% from the year before.
From the Central Coordinating Register
- Org. no.
- 916928521
- Legal form
- AS
- Sector
- Helse og omsorg (86.221)
- Morning company class
- Small
- Employees
- 8 registered 10 July 2026
- Founded
- 1 January 2016 10 years in operation
- Share capital
- 0.03 MNOK
- Business address
- Elvegata 19, 2609 LILLEHAMMER
- Municipality
- Lillehammer rank 3–14 of 27 in KOSTRA group 9
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 1 November 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 31 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 49 | 41 | 47 | |
| Rank | 970 | 1,379 | 1,179 | |
| Operating margin | 50.1% | 59.9% | 57.9% | |
| Return on assets | 85.9% | 81.8% | 90.0% | |
| Equity ratio | 12.9% | 0.7% | 1.2% | |
| Current ratio | 1.05 | 0.94 | 0.96 | |
| Revenue growth | – | −0.5% | 4.0% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 11.2 MNOK | 11.2 MNOK | 11.6 MNOK |
| Operating profit | 5.6 MNOK | 6.7 MNOK | 6.7 MNOK |
| Profit before tax | 5.6 MNOK | 6.7 MNOK | 6.7 MNOK |
| Net profit | 4.4 MNOK | 5.2 MNOK | 5.2 MNOK |
| Financial expenses | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Total assets | 6.6 MNOK | 8.2 MNOK | 7.5 MNOK |
| Current assets | 6.0 MNOK | 7.7 MNOK | 7.1 MNOK |
| Equity | 0.8 MNOK | 0.1 MNOK | 0.1 MNOK |
| Retained earnings | 0.8 MNOK | 0.0 MNOK | 0.1 MNOK |
| Total liabilities | 5.7 MNOK | 8.1 MNOK | 7.4 MNOK |
| Current liabilities | 5.7 MNOK | 8.1 MNOK | 7.4 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 31 October 2026, accounts id 6054839.
Further
Similar companies
- Pepper Blue Medical AS index 41, rank 1,380 · compare
- Inko AS index 41, rank 1,383 · compare
- Asvo Kvinesdal AS index 41, rank 1,385 · compare
- Clinique Bellevue AS index 41, rank 1,386 · compare
- Innlandet BO og Omsorg AS index 41, rank 1,387 · compare